The Food and Drug Administration approved Nplate for patients with a disorder that causes the body to attack its own platelets, tiny components of blood that help with clotting.
The Food and Drug Administration approved Nplate for patients with a disorder that causes the body to attack its own platelets, tiny components of blood that help with clotting.